Charles Phillips

Charles has extensive experience in medical leadership of face to face meetings with regulators in the US, UK, Canada and Australia. Providing the clinical overview for registration filings of a biologic product, Type II variations on existing products, and CTA/s for new compounds. He also has a track record of success in negotiations with regulators and responding to their questions in a rapid, flexible and credible manner.

Expertise
Clinical-Development, Regulatory, UK